[Skip to Content]
[Skip to Content Landing]
September 20, 1941


Author Affiliations

St. Louis.

JAMA. 1941;117(12):1036. doi:10.1001/jama.1941.02820380058024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Your editorial on aurotherapy in rheumatoid arthritis (The Journal, August 2, p. 368) does not seem to me a fair statement of the present status of gold therapy either in this country or in England.At the last meeting of the American Rheumatism Association an entire morning was devoted to this subject. I believe the majority of the members of that association now agree that gold therapy is the treatment of choice for atrophic arthritis and think that it is especially valuable in early cases.As far as my associates and I can determine, gold is the only known drug that specifically influences the course of atrophic arthritis in a favorable manner. Since our paper on this subject was written we have continued to use gold, and by reducing the weekly dosage to 0.05 Gm. of sodium gold thiomalate, which contains 50 per cent gold, we have

First Page Preview View Large
First page PDF preview
First page PDF preview